Johns Hopkins University The successful candidate(s) for this position will be subject to apre-employment background check.If you are interested in applying for employment with The JohnsHopkins University and require special assistance or accommodationduring any part of the pre-employment process, please contact theHR Business Services Office at [email protected] For TTYusers, call via Maryland Relay or dial 711.The following additional provisions may apply depending on whichcampus you will work. Your recruiter will adviseaccordingly.During the Influenza (“the flu”) season, as a condition ofemployment, The Johns Hopkins Institutions require all employeeswho provide ongoing services to patients or work in patient care orclinical care areas to have an annual influenza vaccination orpossess an approved medical or religious exception. Failure to meetthis requirement may result in termination of employment.The pre-employment physical for positions in clinical areas,laboratories, working with research subjects, or involvingcommunity contact requires documentation of immune status againstRubella (German measles), Rubeola (Measles), Mumps, Varicella(chickenpox), Hepatitis B and documentation of having received theTdap (Tetanus, diphtheria, pertussis) vaccination. This may includedocumentation of having two (2) MMR vaccines; two (2) Varicellavaccines; or antibody status to these diseases from laboratorytesting. Blood tests for immunities to these diseases areordinarily included in the pre-employment physical exam except forthose employees who provide results of blood tests or immunizationdocumentation from their own health care providers. Anyvaccinations required for these diseases will be given at no costin our Occupational Health office.Equal Opportunity EmployerNote: Job Postings are updated daily and remain online untilfilled.EEO is the LawLearn more:https://www1.eeoc.gov/employers/upload/eeoc_self_print_poster.pdfImportant legal informationhttp://hrnt.jhu.edu/legal.cfm Maryland, United States You need to sign in or create an account to save Salary Not Specified Biotechnology & Bioengineering Not specified Full Time jobs in Baltimore LinkedIn Johns Hopkins University Apply(This will open in a new window from which you will be automatically redirected to an external site after 5 seconds) Save Biostatistician Facebook GeneralSummary/PurposeThe Biostatistician willprovide statistical programming and data analysis for the RichmanFamily Precision Medicine Center of Excellence for AlzheimerDisease and related projects.Specific Duties& ResponsibilitiesCollaborate with investigators to developobjectives, designing sampling, randomization, and data collectionprocedures to achieve studyobjectives.Create/build and maintain databases, records,and files.Create and maintain databasedocumentation.Create and maintain documentation ofstatistical methods and computingcode.Use library and web resources to researchstatistical methods.Write statistical computer programs, mergingfiles, creating and recoding variables. Review output forconsistency and quality.Interact with co-investigators to plan dataanalyses and interpret results.Perform data analysis and interpretationutilizing knowledge of programming andstatistics.Generate reports, figures, and tables formanuscripts, presentations, andposters.Participate in the drafting of methods andresults sections of manuscripts, and editing of completemanuscripts.Perform miscellaneous related duties asassigned.MinimumQualificationsMaster’s degree in biostatistics, epidemiology,or related quantitative field.1 year related experience.Demonstrated ability on significant graduate projector additional doctoral education may substitute for experience tothe extent permitted by the JHU equivalencyformula.* JHU Equivalency Formula:30undergraduate degree credits (semester hours) or 18 graduate degreecredits may substitute for one year of experience. Additionalrelated experience may substitute for the required education on thesame basis. For jobs where equivalency is permitted, up to twoyears of non-related college course work may be applied towards thetotal minimum education/experience required for the respective job.*PreferredQualificationsExperience with machine learningpreferred.Experience with electronic health records orother large databases preferred.Experience in psychiatry, neurology or dementiaresearch preferred.SpecialKnowledge, Skills, andAbilitiesProficiency with one or more statisticalpackages (e.g., Stata, SPSS, R, S+), and strong quantitativeskills.Proficient with MSOffice.Problem-solvingskills.Excellent interpersonal and communicationskills (oral and written).Detail-oriented.Able to workindependently.Specific physicalrequirements for the job:Ability to stand, walk or sit for an extendedperiod of time.Reaching by extending hand(s) or arm(s) in anydirection.Finger dexterity required to manipulate objectswith fingers rather than with whole hand(s) or arm(s), for example,using a keyboard.Communication skills using the spokenword.Ability to see within normalparameters.Ability to hear within normalrange.Classified Title:BiostatisticianWorking Title:Biostatistician Role/Level/Range: ACRP/04/MD Starting Salary Range:$68,000 – $80,000; Salarycommensurate with experienceEmployee group: Full Time Schedule: Monday – Friday, 8:30am – 5:00pm / 37.5 hours perweek Exempt Status: ExemptLocation: 33-MD:Johns Hopkins Bayview Department name: 10003820-SOM Psy Bay BV Geriatric andNeuropsychi Personnel area: School of MedicineThe successful candidate(s) for this position will be subject toa pre-employment background check.If you are interested in applying for employment with The JohnsHopkins University and require special assistance or accommodationduring any part of the pre-employment process, please contact theHR Business Services Office [email protected] For TTYusers, call via Maryland Relay or dial 711.The following additional provisions may apply dependingon which campus you will work. Your recruiter will adviseaccordingly.During the Influenza (“the flu”) season, as a condition ofemployment, The Johns Hopkins Institutions require all employeeswho provide ongoing services to patients or work in patient care orclinical care areas to have an annual influenza vaccination orpossess an approved medical or religious exception. Failure to meetthis requirement may result in termination of employment.The pre-employment physical for positions in clinical areas,laboratories, working with research subjects, or involvingcommunity contact requires documentation of immune status againstRubella (German measles), Rubeola (Measles), Mumps, Varicella(chickenpox), Hepatitis B and documentation of having received theTdap (Tetanus, diphtheria, pertussis) vaccination. This may includedocumentation of having two (2) MMR vaccines; two (2) Varicellavaccines; or antibody status to these diseases from laboratorytesting. Blood tests for immunities to these diseases areordinarily included in the pre-employment physical exam except forthose employees who provide results of blood tests or immunizationdocumentation from their own health care providers. Anyvaccinations required for these diseases will be given at no costin our Occupational Health office.Equal Opportunity EmployerNote: Job Postings are updated daily and remain online untilfilled.EEO is the LawLearn more:https://www1.eeoc.gov/employers/upload/eeoc_self_print_poster.pdf Similar jobs Administrative Not specified Full Time jobs in Baltimore Maryland, United States Biostatistician Save Biostatistician Science, Technology & Mathematics Not specified Full Time jobs in Baltimore Johns HopkinsBayview More searches like this Share Maryland, United States Biostatistician Salary Not Specified Faculty Positions Not specified Full Time jobs in Baltimore You need to sign in or create an account to save Twitter Salary Not Specified You need to sign in or create an account to save Biostatistician Johns Hopkins University Save Biostatistician Academic Affairs Not specified Full Time jobs in Baltimore
The National Academy of Inventors (NAI) has named a University of Georgia faculty member who is a leading researcher in regenerative medicine to the 2017 class of NAI Fellows.Steven Stice, Georgia Research Alliance Eminent Scholar and director of the UGA Regenerative Bioscience Center, joins an elite group of 912 innovators who represent more than 250 prestigious research universities and governmental and nonprofit research institutions.Election to NAI Fellow status is a professional distinction accorded to academic inventors who have demonstrated a prolific spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development and the welfare of society. Six UGA faculty members have been named NAI Fellows since the honor was established in 2013, and an additional Fellow joined the faculty last year.“The election of Steven Stice as an NAI Fellow highlights the innovative research conducted at UGA,” said Vice President for Research David Lee. “We join NAI in celebrating his contributions to science and society.”Stice, the D.W. Brooks Distinguished Professor in the College of Agricultural and Environmental Sciences, has led industry and academic research teams in the area of pluripotent stem cells for over 25 years. At UGA he has conducted pioneering work in developmental biology and genetics to advance animal and human medicine. His group derived some of the original human pluripotent stem cell lines placed on the first National Institutes of Health (NIH) human embryonic stem cell registry. Stice was a key member of the team that produced the first cloned rabbit in 1989 and the first cloned transgenic calves in 1998 (George and Charlie), for which he was granted the first U.S. patent in cloning animals. He has produced the first genetically modified pluripotent stem cells derived from pigs and cattle and, more recently, in avian species.His research has led to 16 U.S. patents in stem cells, cloning and regenerative medicine, including the first U.S. patent on animal cloning and therapeutic cloning from adult animal cells. Multiple startup companies have been based on his technologies. ArunA Biomedical, the first company to commercialize a product derived from human pluripotent stem cells, is now using this original stem cell technology as a basis for preclinical human therapeutics and drug delivery.Currently, the Stice lab is collaborating with ArunA Biomedical to develop proprietary exosomes for the treatment of central nervous system injury and neurodegenerative disorders, with an initial focus in stroke. Exosomes — tiny structures shed from cells — are cargo carriers that independently, or when packaged with therapeutics, change the behavior, improve the survival and repair of injured cells, reduce inflammation and attack tumor cells while remaining invisible to the body’s own defenses. Their proprietary manufacturing process will have the ability to noninvasively reach the site of injury without adverse responses while reducing inflammation of the brain and improving neural function.“Steve’s innovative research and entrepreneurial spirit exemplify UGA’s emphasis on translating research discoveries into products that benefit the public,” said Derek Eberhart, director of UGA’s Innovation Gateway. “He has been an integral contributor to the university’s innovation ecosystem, which has generated more than 675 products and 160 companies based on UGA research.”Stice’s longstanding commitment to growing the life science industry, as well as the advancement of regenerative medicine research and commercialization, was recognized in 2017 when he received the Industry Growth Award from Georgia Bio. He has founded five biotech companies, including four startups in Georgia that have generated more than 100 jobs.Stice has published more than 125 peer-reviewed manuscripts and has been an invited speaker at over 200 research conferences, symposia and industry events. In 2016, Stice was invited to serve as a member of the Science Advisory Board to the National Center for Toxicological Research of the Food and Drug Administration. Recently, he led UGA’s participation in a successful bid for $20 million in funding from the National Science Foundation to establish an Engineering Research Center for Cell Manufacturing Technologies in collaboration with the Georgia Institute of Technology and other partner institutions.UGA’s other NAI Fellows are Michael Doyle, retired Regents Professor of Food Microbiology and former director of UGA’s Center for Food Safety; Michael A. Dirr, emeritus professor of horticulture; Robert Ivarie, emeritus professor of genetics; David Chu, Distinguished Research Professor emeritus of pharmacy; and Wayne Hanna, professor of crop and soil sciences. Karen Burg, who joined UGA in 2016 as the Harbor Lights Chair in Small Animal Studies, was named a Fellow in 2014.The university’s innovation programs rank highly, placing top five among all U.S. universities for new products reaching the marketplace for the fourth consecutive year. During the past two years, UGA’s efforts to facilitate industry engagement and catalyze economic development resulted in a 30 percent increase in the number of new inventions and licensing revenue, a 40 percent increase in the pipeline of startup projects, and more than 140 new products reaching the market. Innovation Gateway, formed in 2015 to streamline the path from laboratory or field to marketplace, also brought in $1 million in new grants. The UGA I-Corps Site, a STEM-focused accelerator program funded by a $500,000 grant from the National Science Foundation, launched this fall and helps teams from across the university transition their research discoveries to market-ready products and services.
As your credit union works to navigate the fallout of COVID-19, it’s important to remember the value that your marketing and advertising team can add to your efforts. Through a well-timed, socially responsible advertising campaign, your credit union can help support and comfort your members during this time of uncertainty, while also positively positioning your brand in the communities you serve. Over the last few weeks, we have seen many brands step up and take action against the spread of coronavirus with the launch of COVID-19 related ad campaigns. Overall, the carefully planned response by these brands has been well received by consumers, who have helped many of the ad campaigns go viral. In one of the most popular social media campaigns, Nike was able to harness its brand power to release a public service announcement alongside many of the worlds’ most famous athletes. The ‘Play Inside, Play for the World’ ad campaign is a great lesson in crisis marketing and messaging that credit unions can learn from and apply to their current and future advertising efforts. Through their creative efforts and thoughtful ad placement, Nike was able to balance COVID-19 awareness efforts with their brand messaging, all while avoiding coming off as insensitive or opportunistic. Another instance of a well-planned and timely ad strategy is Guinness’ ‘St. Patrick’s Day Message’. The video reinforces Guinness’ legacy and commitment to its consumers, while also addressing the safety concerns surrounding one of the company’s most profitable and brand-associated holidays. It’s an inspiring and responsible commercial that aligns perfectly with Guinness’ mission/tagline – ‘beer made of more”. Guinness really hit the mark here by staying true to their brand identity and values. Other great examples of brands stepping up to use their advertising and influence to encourage people include: Ford’s ‘Built to Lend a Hand’ television commercial The ‘Chipotle Together’ campaign featuring celebrity hangouts on ZoomCoca-Cola’s Time Square billboard advertisementThe ‘Snack Sized Adventures’ campaign from Nature’s BakeryBud Light’s Dive Bar Tour: Home EditionA primetime television commercial from Sam’s Club IKEA Israel’s coronavirus instructions map PSAThe World Health Organization’s partnership with ‘dude with a sign’ Aviation Gin’s ‘#TipYourBartender’ donation campaign Snapchat and the Ad Council’s ‘Here For You’ mental health featureAs you contemplate your credit union’s marketing strategy going forward, it’s important to remember that while the vast majority of consumers don’t think brands need to stop advertising as a result of COVID-19, according to a new global study by Ace Metrix, they do expect those same brands to be considerate of their overall tone and messaging. That being said, what inspiration and lessons might your credit union take away from the above brands during this time of fear and isolation? How might your credit union repurpose its messaging in a way that is both respectful and helpful, while also communicating your values? Just remember to be empathetic and useful in your marketing and advertising, while also being prepared to switch up your strategy as trends change, consumer sentiment shifts, and/or new details emerge surrounding COVID-19. 3SHARESShareShareSharePrintMailGooglePinterestDiggRedditStumbleuponDeliciousBufferTumblr,Jackson Bolstad Details